Healthcare - Medical - Devices - NASDAQ - US
$ 0.8849
-0.461 %
$ 64.3 M
Market Cap
-1.47
P/E
BALANCE SHEET
94.2 M
ASSETS
9.8 M
LIABILITIES
84.4 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Hyperfine, Inc.
| Current Assets | 88.9 M |
| Cash & Short-Term Investments | 75.2 M |
| Receivables | 4.13 M |
| Other Current Assets | 9.59 M |
| Non-Current Assets | 5.29 M |
| Long-Term Investments | 0 |
| PP&E | 3 M |
| Other Non-Current Assets | 2.29 M |
| Current Liabilities | 8.77 M |
| Accounts Payable | 1.21 M |
| Short-Term Debt | 185 K |
| Other Current Liabilities | 7.37 M |
| Non-Current Liabilities | 1.03 M |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 1.03 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 75.2 | 117.5 | 188.5 | 62.7 | 26.4 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.1 | 2.6 | 0.6 | 0.2 | 0 |
| Inventory | 6.6 | 4.6 | 4.3 | 1.7 | 0 |
| Other Current Assets | 3.0 | 4.0 | 4.0 | 3.8 | 0.8 |
| Total Current Assets | 88.9 | 128.7 | 197.5 | 68.3 | 28.0 |
| PP&E | 3.0 | 3.2 | 3.8 | 1.9 | 0.5 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0.7 | 0 | 44 K | 0 |
| Other Long Term Assets | 2.3 | 1.4 | 1.2 | 1.2 | 2.1 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 94.2 | 134.1 | 202.5 | 71.5 | 30.6 |
| LIABILITIES | |||||
| Accounts Payable | 1.2 | 0.7 | 2.2 | 0.9 | 1.2 |
| Short Term Debt | 0.2 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5.9 | 8.1 | 13.5 | 1.4 | 0.6 |
| Total Current Liabilities | 8.8 | 8.8 | 15.7 | 4.1 | 1.8 |
| Long Term Debt | 0 | 0 | 0 | 0.2 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 64 K | 0 | 0 | 128.3 | 68.6 |
| Total Liabilities | 9.8 | 10.3 | 16.2 | 132.6 | 70.4 |
| EQUITY | |||||
| Common Stock | 7 K | 7 K | 7 K | 0 | 0 |
| Retained Earnings | (253.7) | (209.5) | (136.3) | (71.5) | (48.0) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | (202.5) | 0 | 0 |
| Total Equity | 84.4 | 123.7 | 186.2 | (61.1) | (39.9) |
| Total Liabilities and Equity | 94.2 | 134.1 | 202.5 | 71.5 | 30.6 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 71.3 | 70.4 | 70.3 | 25.2 | 70.0 |